Canopy Growth Corp Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest
Canopy Growth Corp (CGC) reported Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest of -CAD 11.68 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2024-02-09.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest · last filed 2024-02-09
- 2022-12-31: Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 9 month -11.68M CAD.
| Period end | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 9 month |
|---|---|
| 2022-12-31 | -11.68M CAD 10-Q · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |